In this line, another tyrosin-kinase receptor AXL that is highly expressed in aggressive ccRCC tumors and associated with poor outcome has been shown to be a direct target gene of HIF2α but not HIF1α isoform (47). Here, AXL is linked to nonpapillary renal cell carcinoma.